Dextromethorphan Hydrobromide recalls
The FDA has published 3 recalls involving Dextromethorphan Hydrobromide since 2019. The latest was reported on 7 Jun 2023. Most were for potency & assay. Cardinal Health has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls3since 2019
Last 12 months0reported
Class I133% of total
Ongoing0latest 7 Jun 2023
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 1 33%Class II 2 67%Class III 0 0%
Why dextromethorphan hydrobromide is recalled
Companies
Brands
By year
All dextromethorphan hydrobromide recalls, newest first
3 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | G-Supress DX (Dextromethorphan HBr, Guaifenesin recalled by Novis PRG-supress Dx | Novis PR | Packaging Defects | PR |
| Drug | CLASS II | Nuedexta (dextromethorphan HBr recalled by Cardinal HealthNuedexta | Cardinal Health | Manufacturing (CGMP) Deviations | FL, GA, SC |
| Drug | CLASS II | Sorbugen NR (Dextromethorphan HBr, 15 mg recalled by Pharma-NaturalSorbugen | Pharma-Natural | Potency & Assay | Nationwide |
Should you stop taking Dextromethorphan Hydrobromide?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.